retatrutide regulatory approval The FDA has issued warning letters to multiple companies marketing compounded Retatrutide, an investigational drug from Eli Lilly still in Phase II trials. While early studies have shown promising weight-loss results, My thoughts on Retatrutide 🤔🤔

Beyond Weight Loss: The Longevity Revolution While GLP-1 medications like tirzepatide have gained widespread attention for their remarkable weight loss results, emerging research reveals their potential to address aging-related diseases and expand healthy lifespan

A 4-week liraglutide treatment to mice fed high-sucrose corn syrup induced significant reductions in insulin resistance, body and liver weight, and prevented the development of either NAFLD or NASH, unlike in the control group [22]

International researchers examined Swedish health records of almost 95,000 people with a diagnosis of depression or anxiety who were also taking various diabetes medications between 2009 and 2022

Instead They Got Worse. Los Angeles Times, 15 Apr